Primary Hodgkin's disease of the CNS in an immunocompetent patient: a case study and review of the literature.
Primary Hodgkin's disease limited to the CNS is exceedingly rare. Little is known regarding etiologic risk factors, optimal management, and prognosis. A case of Hodgkin's disease confined to the CNS, with cerebrospinal fluid negative for cytology, is described in an immunocompetent patient previously treated for hyperthyroidism with 131I. The patient underwent craniotomy, with resection of two lesions in close proximity within the parenchyma of the temporoparietal lobe. Histopathology revealed classic nodular sclerosing Hodgkin's disease, without evidence of Epstein-Barr viral infection. Treatment included radiation to the whole brain with a boost to the tumor bed. The patient made a full neurologic recovery and remains free of disease recurrence 21 months after treatment. A literature review has identified only 9 additional cases. Seven of 8 evaluable patients remain alive and free of recurrence with a median follow-up of 13 months. The risk factors for this presentation remain undefined. Although follow-up is short, radiotherapy alone appears to provide excellent disease-free survival. Chemotherapy may be reserved for patients with positive cerebrospinal fluid, extracranial disease, or subsequent relapse.
Divisions of Medical Oncology and Hematology, Toronto, Ontario, Canada.
J
J
Biagi
R G
RG
MacKenzie
M S
MS
Lim
M
M
Sapp
N
N
Berinstein
D001932:Brain Neoplasms / Q000000981:diagnostic imaging / Q000209:etiology*; D006689:Hodgkin Disease / Q000000981:diagnostic imaging / Q000209:etiology*; D006801:Humans; D006980:Hyperthyroidism / Q000188:drug therapy; D007121:Immunocompetence; D007457:Iodine Radioisotopes / Q000008:administration & dosage / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D012307:Risk Factors; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
D007457:Iodine Radioisotopes